Headline
The latest stories from AHA Today.
The Federal Emergency Management Agency said that the Defense Production Act is being used to access 60,000 test kits, each with the capacity to serve approximately 300-400 patients.
The AHA, American Medical Association and American Nurses Association urged the public to stay home as the nation continues efforts to combat COVID-19.
The Federal Communications Commission March 20 issued a ruling confirming that the COVID-19 pandemic qualifies as an “emergency” under the Telephone Consumer Protection Act.
A report by Premier, Inc., indicates dramatic spikes in demand for two antimalarial drugs that may influence positive COVID-19 outcomes.
The first Americans Sunday joined a nightly, worldwide movement that began in Europe to show support and gratitude to the nurses, physicians and other health care workers caring for patients during the COVID-19 pandemic.
As requested by AHA, the Centers for Medicare & Medicaid Services issued a corrected announcement regarding the Medicare Severity-Diagnosis Related Group Grouper to recognize the new ICD-10-CM diagnosis code, U07.1, for COVID-19.
The Centers for Medicare & Medicaid Services released a series of COVID-19 checklists and tools for states to use for their Medicaid and Children’s Health Insurance Programs.
The Centers for Medicare & Medicaid Services has released frequently asked questions regarding enrollment relief for Medicare providers in light of COVID-19.
The Food and Drug Administration issued the first emergency use authorization for a point-of-care COVID-19 diagnostic, which the maker plans to make available to qualified health care providers and CLIA-certified labs by March 30.
The Centers for Medicare & Medicaid Services granted a range of data reporting exceptions and extensions across its quality reporting and value-based payment programs for hospitals, post-acute care facilities and clinicians to relieve provider burden during the COVID-19 crisis.